264 related articles for article (PubMed ID: 21248468)
21. Global reorganization of the nuclear landscape in senescent cells.
Chandra T; Ewels PA; Schoenfelder S; Furlan-Magaril M; Wingett SW; Kirschner K; Thuret JY; Andrews S; Fraser P; Reik W
Cell Rep; 2015 Feb; 10(4):471-83. PubMed ID: 25640177
[TBL] [Abstract][Full Text] [Related]
22. Aging, cellular senescence, and cancer.
Campisi J
Annu Rev Physiol; 2013; 75():685-705. PubMed ID: 23140366
[TBL] [Abstract][Full Text] [Related]
23. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.
Baker DJ; Wijshake T; Tchkonia T; LeBrasseur NK; Childs BG; van de Sluis B; Kirkland JL; van Deursen JM
Nature; 2011 Nov; 479(7372):232-6. PubMed ID: 22048312
[TBL] [Abstract][Full Text] [Related]
24. Cellular senescence and tumor suppressor gene p16.
Rayess H; Wang MB; Srivatsan ES
Int J Cancer; 2012 Apr; 130(8):1715-25. PubMed ID: 22025288
[TBL] [Abstract][Full Text] [Related]
25. Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation.
Chandra T; Kirschner K; Thuret JY; Pope BD; Ryba T; Newman S; Ahmed K; Samarajiwa SA; Salama R; Carroll T; Stark R; Janky R; Narita M; Xue L; Chicas A; Nũnez S; Janknecht R; Hayashi-Takanaka Y; Wilson MD; Marshall A; Odom DT; Babu MM; Bazett-Jones DP; Tavaré S; Edwards PA; Lowe SW; Kimura H; Gilbert DM; Narita M
Mol Cell; 2012 Jul; 47(2):203-14. PubMed ID: 22795131
[TBL] [Abstract][Full Text] [Related]
26. Detection of the senescence-associated secretory phenotype (SASP).
Rodier F
Methods Mol Biol; 2013; 965():165-73. PubMed ID: 23296657
[TBL] [Abstract][Full Text] [Related]
27. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype.
Freund A; Patil CK; Campisi J
EMBO J; 2011 Apr; 30(8):1536-48. PubMed ID: 21399611
[TBL] [Abstract][Full Text] [Related]
28. Senescence and aging: the critical roles of p53.
Rufini A; Tucci P; Celardo I; Melino G
Oncogene; 2013 Oct; 32(43):5129-43. PubMed ID: 23416979
[TBL] [Abstract][Full Text] [Related]
29. Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape.
Shah PP; Donahue G; Otte GL; Capell BC; Nelson DM; Cao K; Aggarwala V; Cruickshanks HA; Rai TS; McBryan T; Gregory BD; Adams PD; Berger SL
Genes Dev; 2013 Aug; 27(16):1787-99. PubMed ID: 23934658
[TBL] [Abstract][Full Text] [Related]
30. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan.
Baker DJ; Childs BG; Durik M; Wijers ME; Sieben CJ; Zhong J; Saltness RA; Jeganathan KB; Verzosa GC; Pezeshki A; Khazaie K; Miller JD; van Deursen JM
Nature; 2016 Feb; 530(7589):184-9. PubMed ID: 26840489
[TBL] [Abstract][Full Text] [Related]
31. Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence.
Sadaie M; Salama R; Carroll T; Tomimatsu K; Chandra T; Young AR; Narita M; Pérez-Mancera PA; Bennett DC; Chong H; Kimura H; Narita M
Genes Dev; 2013 Aug; 27(16):1800-8. PubMed ID: 23964094
[TBL] [Abstract][Full Text] [Related]
32. Lamin B1 loss is a senescence-associated biomarker.
Freund A; Laberge RM; Demaria M; Campisi J
Mol Biol Cell; 2012 Jun; 23(11):2066-75. PubMed ID: 22496421
[TBL] [Abstract][Full Text] [Related]
33. Morphological and Functional Characteristic of Senescent Cancer Cells.
Sikora E; Mosieniak G; Sliwinska MA
Curr Drug Targets; 2016; 17(4):377-87. PubMed ID: 26477465
[TBL] [Abstract][Full Text] [Related]
34. Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model.
Burd CE; Sorrentino JA; Clark KS; Darr DB; Krishnamurthy J; Deal AM; Bardeesy N; Castrillon DH; Beach DH; Sharpless NE
Cell; 2013 Jan; 152(1-2):340-51. PubMed ID: 23332765
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
[TBL] [Abstract][Full Text] [Related]
36. BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss.
Tu Z; Zhuang X; Yao YG; Zhang R
Mol Cell Biol; 2013 May; 33(9):1819-29. PubMed ID: 23438604
[TBL] [Abstract][Full Text] [Related]
37. A complex secretory program orchestrated by the inflammasome controls paracrine senescence.
Acosta JC; Banito A; Wuestefeld T; Georgilis A; Janich P; Morton JP; Athineos D; Kang TW; Lasitschka F; Andrulis M; Pascual G; Morris KJ; Khan S; Jin H; Dharmalingam G; Snijders AP; Carroll T; Capper D; Pritchard C; Inman GJ; Longerich T; Sansom OJ; Benitah SA; Zender L; Gil J
Nat Cell Biol; 2013 Aug; 15(8):978-90. PubMed ID: 23770676
[TBL] [Abstract][Full Text] [Related]
38. The cell fate: senescence or quiescence.
Terzi MY; Izmirli M; Gogebakan B
Mol Biol Rep; 2016 Nov; 43(11):1213-1220. PubMed ID: 27558094
[TBL] [Abstract][Full Text] [Related]
39. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA.
Demaria M; Ohtani N; Youssef SA; Rodier F; Toussaint W; Mitchell JR; Laberge RM; Vijg J; Van Steeg H; Dollé ME; Hoeijmakers JH; de Bruin A; Hara E; Campisi J
Dev Cell; 2014 Dec; 31(6):722-33. PubMed ID: 25499914
[TBL] [Abstract][Full Text] [Related]
40. Senescence and apoptosis: dueling or complementary cell fates?
Childs BG; Baker DJ; Kirkland JL; Campisi J; van Deursen JM
EMBO Rep; 2014 Nov; 15(11):1139-53. PubMed ID: 25312810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
